Elara Caring Xxv | |
721 South George Nigh Expressway, Suite 3, Mcalester, Oklahoma 74501 | |
(855) 527-7473 | |
Name | Elara Caring Xxv |
---|---|
Location | 721 South George Nigh Expressway, Suite 3, Mcalester, Oklahoma |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
Medicare ID | 377667 |
Ownership Type | Proprietary |
Service Area Zip Codes | 74006, 74008, 74010, 74011, 74012, 74014, 74015, 74016, 74017, 74018, 74019, 74020, 74021, 74027, 74028, 74033, 74035, 74036, 74037, 74038, 74039, 74041, 74044, 74048, 74053, 74054, 74055, 74056, 74060, 74063, 74066, 74070, 74071, 74073, 74102, 74104, 74105, 74106, 74107, 74108, 74110, 74112, 74114, 74115, 74116, 74119, 74120, 74126, 74127, 74128, 74129, 74130, 74131, 74132, 74133, 74135, 74136, 74137, 74145, 74146, 74330, 74337, 74342, 74346, 74352, 74361, 74365, 74401, 74403, 74425, 74426, 74429, 74431, 74432, 74436, 74437, 74445, 74447, 74455, 74460, 74467, 74501, 74502, 74525, 74536, 74538, 74547, 74553, 74554, 74560, 74561, 74565, 74569, 74570, 74571, 74574, 74578, 74845, 74850, 74871, 74880 |
Quality Rating: |
News Archive
ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that it has entered into an agreement with Medtronic, Inc., a leader in medical technologies to improve the treatment of chronic diseases, including cardiac rhythm disorders, to collaborate on ARCA's proposed clinical trial, known as GENETIC-AF, of its lead developmental drug Gencaro (bucindolol hydrochloride).
How Swine Flu Overturned the Understanding of Pandemic Outbreaks. As H1N1 'Swine Flu' returns to the national headlines a new research paper reveals the key lessons about the origins of the 2009 pandemic. The paper, published today in BioEssays, reveals how the pandemic challenges the traditional understanding of 'antigenic shift', given that the virus emerged from an existing influenza subtype.
ImmunoGen, Inc. (NASDAQ: IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today announced the first findings from Company research aimed at optimizing the dosing of its IMGN853 product candidate.
The Neonatal Intensive Care Unit (NICU) at Children's Medical Center has been designated a Level IV NICU, the highest qualification for such programs, as established by the American Academy of Pediatrics under newly revised standards.
› Verified 7 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often the home health team began their patients’ care in a timely manner | 94.4 | 95.7 |
How often the home health team taught patients (or their family caregivers) about their drugs | 98.8 | 98.6 |
How often the home health team checked patients’ risk of falling | 99.7 | 99.6 |
How often the home health team checked patients for depression | 97.2 | 97.4 |
How often the home health team made sure that their patients have received a flu shot for the current flu season. | 87.9 | 78.7 |
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 87.5 | 82.2 |
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 97.6 | 96.4 |
News Archive
ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that it has entered into an agreement with Medtronic, Inc., a leader in medical technologies to improve the treatment of chronic diseases, including cardiac rhythm disorders, to collaborate on ARCA's proposed clinical trial, known as GENETIC-AF, of its lead developmental drug Gencaro (bucindolol hydrochloride).
How Swine Flu Overturned the Understanding of Pandemic Outbreaks. As H1N1 'Swine Flu' returns to the national headlines a new research paper reveals the key lessons about the origins of the 2009 pandemic. The paper, published today in BioEssays, reveals how the pandemic challenges the traditional understanding of 'antigenic shift', given that the virus emerged from an existing influenza subtype.
ImmunoGen, Inc. (NASDAQ: IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today announced the first findings from Company research aimed at optimizing the dosing of its IMGN853 product candidate.
The Neonatal Intensive Care Unit (NICU) at Children's Medical Center has been designated a Level IV NICU, the highest qualification for such programs, as established by the American Academy of Pediatrics under newly revised standards.
› Verified 7 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often patients got better at walking or moving around | 82.3 | 79.6 |
How often patients got better at getting in and out of bed | 79.7 | 81.1 |
How often patients got better at bathing | 83.1 | 82.3 |
How often patients’ breathing improved | 78.9 | 82.8 |
How often patients’ wounds improved or healed after an operation | 93.9 | 92.3 |
How often patients got better at taking their drugs correctly by mouth | 74.8 | 75 |
How often home health patients had to be admitted to the hospital | 15.5 | 15.4 |
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 14.2 | 13 |
How often physician-recommended actions to address medication issues were completely timely | 96.7 | 94 |
News Archive
ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that it has entered into an agreement with Medtronic, Inc., a leader in medical technologies to improve the treatment of chronic diseases, including cardiac rhythm disorders, to collaborate on ARCA's proposed clinical trial, known as GENETIC-AF, of its lead developmental drug Gencaro (bucindolol hydrochloride).
How Swine Flu Overturned the Understanding of Pandemic Outbreaks. As H1N1 'Swine Flu' returns to the national headlines a new research paper reveals the key lessons about the origins of the 2009 pandemic. The paper, published today in BioEssays, reveals how the pandemic challenges the traditional understanding of 'antigenic shift', given that the virus emerged from an existing influenza subtype.
ImmunoGen, Inc. (NASDAQ: IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today announced the first findings from Company research aimed at optimizing the dosing of its IMGN853 product candidate.
The Neonatal Intensive Care Unit (NICU) at Children's Medical Center has been designated a Level IV NICU, the highest qualification for such programs, as established by the American Academy of Pediatrics under newly revised standards.
› Verified 7 days ago
Question Type: | Rating by Patients |
---|---|
Health team gave care in a professional way | |
Health team communicated well with them | |
Health team discussed medicines, pain, and home safety | |
How patients rated overall care from agency |
News Archive
ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that it has entered into an agreement with Medtronic, Inc., a leader in medical technologies to improve the treatment of chronic diseases, including cardiac rhythm disorders, to collaborate on ARCA's proposed clinical trial, known as GENETIC-AF, of its lead developmental drug Gencaro (bucindolol hydrochloride).
How Swine Flu Overturned the Understanding of Pandemic Outbreaks. As H1N1 'Swine Flu' returns to the national headlines a new research paper reveals the key lessons about the origins of the 2009 pandemic. The paper, published today in BioEssays, reveals how the pandemic challenges the traditional understanding of 'antigenic shift', given that the virus emerged from an existing influenza subtype.
ImmunoGen, Inc. (NASDAQ: IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today announced the first findings from Company research aimed at optimizing the dosing of its IMGN853 product candidate.
The Neonatal Intensive Care Unit (NICU) at Children's Medical Center has been designated a Level IV NICU, the highest qualification for such programs, as established by the American Academy of Pediatrics under newly revised standards.
› Verified 7 days ago
The patient survey data of Elara Caring Xxv is compared against the national average with the color code indicators: Better than National Average Worse than National AverageExperience Measure | Provider | National Avg. |
---|---|---|
Percent of patients who reported that their home health team gave care in a professional way | 88 | 88 |
Percent of patients who reported that their home health team communicated well with them | 86 | 85 |
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 78 | 83 |
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 81 | 84 |
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 71 | 78 |
News Archive
ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that it has entered into an agreement with Medtronic, Inc., a leader in medical technologies to improve the treatment of chronic diseases, including cardiac rhythm disorders, to collaborate on ARCA's proposed clinical trial, known as GENETIC-AF, of its lead developmental drug Gencaro (bucindolol hydrochloride).
How Swine Flu Overturned the Understanding of Pandemic Outbreaks. As H1N1 'Swine Flu' returns to the national headlines a new research paper reveals the key lessons about the origins of the 2009 pandemic. The paper, published today in BioEssays, reveals how the pandemic challenges the traditional understanding of 'antigenic shift', given that the virus emerged from an existing influenza subtype.
ImmunoGen, Inc. (NASDAQ: IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today announced the first findings from Company research aimed at optimizing the dosing of its IMGN853 product candidate.
The Neonatal Intensive Care Unit (NICU) at Children's Medical Center has been designated a Level IV NICU, the highest qualification for such programs, as established by the American Academy of Pediatrics under newly revised standards.
› Verified 7 days ago
Healthback Of Mcalester Location: 1102 E Washington Ave, Mcalester, Oklahoma 74501 Ratings: Phone: (918) 423-2034 | |
Mcalester Regional Health Center Location: 901 E Vanburen, Mcalester, Oklahoma 74501 Ratings: Phone: (918) 421-8018 | |
Green Country Home Care, Inc Location: 405 Chickasaw Street, Mcalester, Oklahoma 74501 Ratings: Phone: (918) 426-1005 | |
Oklahoma Healthcare Solutions Viii Location: 315 E Wyandotte, Ste B, Mcalester, Oklahoma 74501 Ratings: Phone: (918) 421-8822 | |
Traditions Home Care, Inc Location: 100 S 3rd Street, Mcalester, Oklahoma 74501 Ratings: Phone: (918) 426-0983 | |
Elara Caring Xxv Location: 721 South George Nigh Expressway, Suite 3, Mcalester, Oklahoma 74501 Ratings: Phone: (855) 527-7473 |